SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
295 17 0 PSTI
Emcee:  FJB Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70Pluristem Therapeutics to Present at the Tel-Aviv Stock Exchange NEW YORK, Aprxcentral1-4/20/2009
69Pluristem Therapeutics to Sponsor the World Conference on Regenerative Medicine xcentral1-4/9/2009
68Pluristem Therapeutics to Present at the German Equity Forum NEW YORK, Mar 31,xcentral1-3/31/2009
67Pluristem Therapeutics to Present at "The Stem Cell Network" Conferencxcentral1-3/17/2009
66Pluristem Therapeutics Prepares For Placental-Derived Stem Cell Clinical Trial xcentral1-3/11/2009
65Pluristem Therapeutics Receives FDA Clearance to Begin "First-In-Human"idos-3/2/2009
64Pluristem Therapeutics Collaborates with Pharmicell Europe GmbH to Distribute Plxcentral1-2/24/2009
63Pluristem Therapeutics to Present at Italian CREM Workshop Focused on Placental-xcentral1-2/19/2009
62Pluristem names new vice president of R&D Fri. February 13, 2009; Posted: 07xcentral1-2/15/2009
61Pluristem Therapeutics’ cGMP Facilities Approved for Clinical Manufacturing in Excentral1-2/2/2009
60Pluristem Therapeutics Collaborates with the Charité - Universitätsmedxcentral1-1/27/2009
59Pluristem Therapeutics Files An IND Application With The FDA To Initiate A Phasexcentral1-1/14/2009
58Pluristem Therapeutics Inc. Announces Filing an IMPD to Commence Clinical Trialsxcentral1-12/16/2008
57Pluristem gets $1.6m Chief Scientist grant: The company and its European partnerxcentral1-12/16/2008
56Pluristem raises $1m in private placement: The company expects to begin clinicalxcentral1-9/26/2008
55Some of my lots were bought higher than that... IMHO - this value suggests a coxcentral1-9/24/2008
54That is amazing; they think the warrants are worth that much?! Not clear why anSG-9/23/2008
53Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced it has entered into dxcentral1-9/23/2008
52Pluristem Presents Final PLX-PAD Efficacy Data Supporting Upcoming IND Submissioxcentral1-9/16/2008
51Pluristem's PLX-MS Shows Potential Benefit in the Prevention of Multiple Sclxcentral1-8/11/2008
50Pluristem Therapeutics Announces $1.6 Million Securities Offering BUSINESS WIRE xcentral1-8/7/2008
49Dutton Associates Announces Investment Opinion: Pluristem Therapeutics Speculatixcentral1-7/30/2008
48The Esteemed Dr. Brian Annex Accepts Pluristem's Invitation to Join its Sciexcentral1-7/29/2008
47Pluristem's PLX-BMT Product Featured in the Journal ''Expert Opinionxcentral1-7/17/2008
46Ramping up !!! Pluristem Certified as a Good Manufacturing Practices (GMP) Site xcentral1-6/26/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News